CLINICAL_TRIALS
trial_result
· 2019-10-04
Clinical Trial Update: p38 Mitogen-Activated Protein Kinase (MAPK) and Steroid Insensitivity in Asthma
Summary
Clinical trial update on p38 MAPK pathway and steroid insensitivity in asthma; results have been posted following completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Imperial College London | Conditions: Asthma | Status: COMPLETED | Results posted: 2019-10-04